Health Observer Falkland Islands
SEE OTHER BRANDS

Daily news on health and wellness in the Falkland Islands

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on August 15, 2025

HeartSciences Announces Conference Participation and Investor Webinar

HeartSciences Announces Conference Participation and Investor Webinar

Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no …

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; BGE-102 demonstrated robust weight loss …

Cingulate Provides Management Team Update

Cingulate Provides Management Team Update

Jennifer Callahan, Chief Financial Officer, appointed Interim CEO Board member, Jay Roberts appointed Executive Chairman KANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CING) The Board of Directors of Cingulate Inc. (“Cingulate”) announced …

Animal Antibiotics and Antimicrobials Market Size, Share, Competitive Landscape and Trend Analysis Report

Animal Antibiotics and Antimicrobials Market Size, Share, Competitive Landscape and Trend Analysis Report

The Business Research Company’s Animal Antibiotics and Antimicrobials Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 15, 2025 /⁨EINPresswire.com⁩/ -- How Large Will The Animal …

Animal Based Protein Supplements Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

Animal Based Protein Supplements Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

The Business Research Company’s Animal Based Protein Supplements Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 15, 2025 /⁨EINPresswire.com⁩/ -- What Is The Forecast For The Animal …

Aquafeed Additives Market Size, Share & Trends Analysis Report By Product

Aquafeed Additives Market Size, Share & Trends Analysis Report By Product

The Business Research Company’s Aquafeed Additives Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 15, 2025 /⁨EINPresswire.com⁩/ -- What Is The Aquafeed Additives Market Size And …

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

– Live video webcast on Thursday, August 21st at 2:20 PM ET THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted …

Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market

Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market

SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) --  Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™

Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Innovations in supply chain management and the rise of direct-to-patient models are transforming how life sciences companies execute global clinical trials. The global clinical trial supplies market, …

Sienna Announces August Dividend

Sienna Announces August Dividend

MARKHAM, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of August 2025, representing $0 …

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies

Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug …

Global Digital Pathology Market to Reach $13.7 Billion in 2029

Global Digital Pathology Market to Reach $13.7 Billion in 2029

Boston, Aug. 15, 2025 (GLOBE NEWSWIRE) -- As global demand for precision diagnostics rises, digital pathology is reshaping how clinical labs, research institutions, and healthcare systems operate. From AI-assisted image analysis to remote pathology …

Pallet Racking Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights

Pallet Racking Industry Analysis Report 2025: Key Trends, Drivers, and Forecast Insights

The Business Research Company's Pallet Racking Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 15, 2025 /⁨EINPresswire.com⁩/ -- Pallet Racking Market Growth Forecast: What To …

Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split

Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split

FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American:   VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that …

Stryker to host investor day

Stryker to host investor day

Portage, Michigan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Investor Day on Thursday, November 13, 2025, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A live audio webcast of the session, along with a replay, …

Global Wound Care Market Set to Surpass USD 30.48 Billion by 2030 | MarketsandMarkets™

Global Wound Care Market Set to Surpass USD 30.48 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Growing demand for advanced wound management solutions meets innovation and strategic expansion across global healthcare systems The global wound care market, valued at US$20.97 billion in 2024, stood at …

Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements

Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements

HOUSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) --  Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been completed; top-line results are expected in the fourth quarter of 2026 Phase-1b proof-of-concept clinical trial of SGT-210 for Darier disease is ongoing Sol- …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions